One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

@article{Fujita2015OneyearOW,
  title={One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.},
  author={Kyoko Fujita and Yutaka Imamura and Kei Shinoda and Celso Soiti Matsumoto and Yoshihiro Mizutani and Kouhei Hashizume and Atsushi Mizota and Mitsuko Yuzawa},
  journal={Ophthalmology},
  year={2015},
  volume={122 3},
  pages={555-61}
}
PURPOSE To assess the 1-year outcome of half-dose verteporfin photodynamic therapy (PDT) for patients with chronic central serous chorioretinopathy (CSC). DESIGN Retrospective, interventional case series with no controls. PARTICIPANTS A total of 204 eyes of 204 patients with chronic CSC were studied. METHODS Fluorescein angiography (FA) and indocyanine green angiography (ICGA) were performed before PDT. The best-corrected visual acuities (BCVAs) were measured and optical coherence… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology • 2016
View 6 Excerpts
Highly Influenced

A Multicenter Randomized Controlled Study of Antioxidant Supplementation with Lutein for Chronic Central Serous Chorioretinopathy.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde • 2017

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…